Scientists have created tiny disk-shaped particles that can swim on their own when hit with light, akin to microscopic robots ...

A groundbreaking wireless implant promises real-time, personalized pain relief using AI and ultrasound power no batteries, no ...

Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll ...

Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) ...

Revuforj is designed to treat patients with relapsed or refractory mutant NPM1 acute myeloid leukemia. The application has been assigned a real-time oncology review, which allows for a more efficient ...

The program will bring together experts from across the FDA for a team-based review, rather than having an application move ...

While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers ...

The investigational MRI contrast agent, gadoquatrane, is designed to deliver effective imaging at a significantly reduced ...

The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with national priorities to shorten their review time for a drug application to ...